 |
Alchemia
(ASX:ACL) Oncology company with expertise in carbohydrate chemistry |
 |
Aragon Pharmaceuticals
Biopharma company developing small molecule drugs to treat hormone-resistant cancers (prostate and breast).
|
 |
AudeƓ Oncology
Late stage biopharmaceutical company utilizing a Hyaluronic Acid Chemotransport Technology (HyACT), to target cancer drugs preferentially to tumor cells to enhance drug activity.
|
 |
Biota
(Nasdaq:BOTA) Anti-infective drug company with expertise in respiratory diseases |
 |
Cerus Corporation
(Nasdaq:CERS) Biomedical products company commercializing the INTERCEPT Blood System to enhance blood safety |
 |
Genetic Technologies
(ASX:GTG, Nasdaq:GENE) Genetic testing company specializing in breast cancer diagnostics |
 |
Mast Therapeutics
(NYSE MKT: MSTX) Biopharma company leveraging proprietary MAST platform to treat diseases with significant unmet medical need across hematology |
 |
Sunshine Heart
(ASX:SHC, Nasdaq:SSH) Medical device company developing the C-Pulse Heart Assist System for Class III/ambulatory Class IV (moderate to severe) heart failure |
 |
SymBio Pharmaceuticals
(Jasdaq:4582) Specialty biopharmaceutical company focused on developing drug candidates indicated for 'orphan' or 'orphan-like' diseases in Asia |
 |
Vital Therapies
(private) Biomedical company developing the first liver cell-based system for the treatment of liver disease |